Maternal HIV and Paediatric Lung Health

Paediatr Respir Rev. 2017 Jan:21:47-53. doi: 10.1016/j.prrv.2016.08.004. Epub 2016 Aug 19.

Abstract

With improved prevention of mother to child transmission of HIV, paediatric HIV disease is less common. However, the number of HIV exposed but uninfected infants is growing. Exposure to maternal HIV impacts infant respiratory health through an increase in known risk factors such as increased preterm birth and low birth weight, suboptimal breastfeeding, increased psychosocial stressors and increased exposure to infective pathogens. Exposure to the HIV virus and altered maternal immune environment result in immunologic changes in the infant that may contribute to respiratory disease risk. HIV exposed infants are at increased risk for severe pneumonia with poorer outcomes compared to unexposed infants. Maternal ART and optimal nutrition, including breastfeeding in high infective disease burden settings, reduce morbidity and mortality in HIV exposed infants and should be prioritized. The impact of exposure to maternal HIV on normal lung growth and risk for chronic respiratory disease is unknown and warrants further investigation.

Keywords: HIV; infant; maternal exposure; respiratory disease.

Publication types

  • Review

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Breast Feeding
  • Child
  • Cytomegalovirus Infections / epidemiology
  • Female
  • HIV Infections / diagnostic imaging
  • HIV Infections / epidemiology*
  • HIV Infections / immunology
  • Humans
  • Infant, Newborn
  • Lung / embryology*
  • Lung / growth & development
  • Lung / immunology
  • Pneumococcal Infections / epidemiology
  • Pneumonia, Pneumocystis / epidemiology
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnancy Complications, Infectious / immunology
  • Prenatal Exposure Delayed Effects / epidemiology*
  • Respiratory Tract Diseases / epidemiology*
  • Respiratory Tract Diseases / immunology
  • Socioeconomic Factors
  • Tuberculosis / epidemiology

Substances

  • Anti-Retroviral Agents